Sopan Pharmaceuticals Limited (SOPL) Share Price & Fundamentals
Sopan Pharmaceuticals (SOPL) share price is Rs. 748.90, down 0.68% on 2026-09-22. Open Rs. 750.00. High Rs. 757.90. Low Rs. 741.00. Volume 24,223.
Sopan Pharmaceuticals Limited is a NEPSE-listed company (SOPL), Manufacturing And Processing sector. Revenue: Rs. 50.05 Crore. Net profit: Rs. 21.78 Crore. Net worth: Rs. 161.6 Crore.
About Sopan Pharmaceuticals Limited
Sopan Pharmaceuticals Limited (SOPL) has 1,71,60,000 shares outstanding.
SOPL key metrics
SOPL strengths
What Sopan Pharmaceuticals Limited's own accounts show in its favour, graded against the rest of its sector.
- Keeps 53.5% of every sale once the day to day costs of running the business are paid. (Margins)
- Turns 41.9% of every sale into final profit after all costs, interest and tax. (Margins)
- Can settle its short term bills 3.79x over, so it is unlikely to run short of cash. (Liquidity)
- Sales grew 229.9% on last year, so more customers are buying or prices have risen. (Growth)
- Keeps 76% of every sale after paying to make the product, leaving room for running costs and profit. (Margins)
- Debt sits at just 0.34x of shareholders' money, so lenders have little claim on the company. (Leverage & Solvency)
- Covers short term bills 3.23x over even without selling any stock, which is a strong cash position. (Liquidity)
- Shareholders' stake in the company grew 48.1% over the year, so value is building up. (Shareholder Returns)
- Earns 57.3% on everything it takes in, before interest and tax are paid. (Profitability)
- 69.5% of everything it owns was paid for by shareholders rather than borrowed. (Leverage & Solvency)
- Earns 13.5% a year on the money shareholders have put in, which is the return owners actually get. (Profitability)
- Profits cover the interest bill 5.24x over, so loan payments are comfortably affordable. (Leverage & Solvency)
- What the company owns grew 18%, which usually means it is investing to get bigger. (Growth)
- Earns 9.4% a year on everything it owns, so its buildings, stock and cash are being put to work. (Profitability)
- Buildings and machinery are a modest 63.5% of assets, so it is not tied to heavy fixed costs. (Efficiency)
SOPL weaknesses
What the same accounts show against it. Both lists are computed from the filed figures, not opinion, and are not advice.
- Every rupee of assets brings in only 0.22x of sales, so its assets generate little trade. (Efficiency)
- Stock turns over 1.16x a year, so cash stays tied up in unsold goods. (Efficiency)
- Cash is only 0.4% of what it owns, so there is little spare for a surprise. (Liquidity)
- Return on the money tied up in the business is 13.9%, so capital is not working hard. (Profitability)
SOPL annual results 2081/82
For the financial year 2081/82 Sopan Pharmaceuticals Limited reported net profit of Rs. 21.78 crore, revenue from operations of Rs. 50.05 crore and net worth of Rs. 161.6 crore. Net profit in 2080/81 was a loss of Rs. 8.27 crore. Net profit turned from a loss to a profit on the year. Revenue from operations grew 229.90% on the year.
SOPL profit and loss for 2081/82
In the financial year 2081/82, Sopan Pharmaceuticals Limited reported revenue from operations of Rs. 50.05 crore, gross profit of Rs. 38.04 crore, operating profit of Rs. 29.82 crore, profit before tax of Rs. 24.13 crore and net profit for the year of Rs. 21.78 crore.
Reported under gross profit: cost of sales of Rs. 12.02 crore. Reported under operating profit: other income of Rs. 1.97 crore, selling and distribution expenses of Rs. 4.07 crore, administrative expenses of Rs. 4.27 crore, employee benefit expenses of Rs. 0 crore, depreciation and amortisation of Rs. 1.85 crore, allowance for expected credit loss of Rs. 0 crore and other operating expenses of Rs. 0 crore. Reported under profit before tax: finance costs of Rs. 5.69 crore and gain on investments through fair value of Rs. 0 crore. Reported under net profit for the year: current tax of Rs. 0 crore, deferred tax of Rs. 2.35 crore and prior period tax adjustment of Rs. 0 crore.
SOPL profit and loss for 2080/81
In the financial year 2080/81, Sopan Pharmaceuticals Limited reported revenue from operations of Rs. 15.17 crore, gross profit of Rs. 5.23 crore, operating profit of Rs. 1.81 crore, profit before tax of Rs. 10.33 crore and net profit for the year of Rs. 8.27 crore.
Reported under gross profit: cost of sales of Rs. 9.94 crore. Reported under operating profit: other income of Rs. 3.01 crore, selling and distribution expenses of Rs. 4.36 crore, administrative expenses of Rs. 4.06 crore, employee benefit expenses of Rs. 0 crore, depreciation and amortisation of Rs. 1.62 crore, allowance for expected credit loss of Rs. 0 crore and other operating expenses of Rs. 0 crore. Reported under profit before tax: finance costs of Rs. 8.53 crore and gain on investments through fair value of Rs. 0 crore. Reported under net profit for the year: current tax of Rs. 0 crore, deferred tax of Rs. 2.07 crore and prior period tax adjustment of Rs. 0 crore.
SOPL profit and loss for 2079/80
In the financial year 2079/80, Sopan Pharmaceuticals Limited reported revenue from operations of Rs. 14.03 crore, gross profit of Rs. 2.68 crore, operating profit of Rs. 8.79 crore, profit before tax of Rs. 18.26 crore and net profit for the year of Rs. 28.65 crore.
Reported under gross profit: cost of sales of Rs. 11.34 crore. Reported under operating profit: other income of Rs. 0.01 crore, selling and distribution expenses of Rs. 5.3 crore, administrative expenses of Rs. 4.44 crore, employee benefit expenses of Rs. 0 crore, depreciation and amortisation of Rs. 1.74 crore, allowance for expected credit loss of Rs. 0 crore and other operating expenses of Rs. 0 crore. Reported under profit before tax: finance costs of Rs. 9.47 crore and gain on investments through fair value of Rs. 0 crore. Reported under net profit for the year: current tax of Rs. 0 crore, deferred tax of Rs. 10.39 crore and prior period tax adjustment of Rs. 0 crore.
SOPL balance sheet for 2081/82
In the financial year 2081/82, Sopan Pharmaceuticals Limited reported total non-current assets of Rs. 162.5 crore, total current assets of Rs. 69.95 crore, total equity of Rs. 161.6 crore, total non-current liabilities of Rs. 52.37 crore and total current liabilities of Rs. 18.48 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 147.5 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 0 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 15 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 10.34 crore, trade receivables of Rs. 56.27 crore, cash and cash equivalents of Rs. 1.03 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 2.32 crore, income tax assets (net) of Rs. 0 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 0 crore and other current assets of Rs. 0 crore. Reported under total equity: share capital of Rs. 128.7 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 32.9 crore, retained earnings of Rs. 0 crore, other equity of Rs. 0 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 43.84 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 8.03 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0.5 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 10.73 crore, trade payables of Rs. 4.07 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore, other current liabilities of Rs. 3.68 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
SOPL balance sheet for 2080/81
In the financial year 2080/81, Sopan Pharmaceuticals Limited reported total non-current assets of Rs. 167.89 crore, total current assets of Rs. 29.1 crore, total equity of Rs. 109.09 crore, total non-current liabilities of Rs. 63.43 crore and total current liabilities of Rs. 24.46 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 167.88 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 0 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 0 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 6.58 crore, trade receivables of Rs. 19.24 crore, cash and cash equivalents of Rs. 1.51 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 1.76 crore, income tax assets (net) of Rs. 0 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 0 crore and other current assets of Rs. 0 crore. Reported under total equity: share capital of Rs. 99 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 10.09 crore, retained earnings of Rs. 0 crore, other equity of Rs. 0 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 54.99 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 5.68 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 2.76 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 14.6 crore, trade payables of Rs. 2.73 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore, other current liabilities of Rs. 7.13 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
SOPL balance sheet for 2079/80
In the financial year 2079/80, Sopan Pharmaceuticals Limited reported total non-current assets of Rs. 167.23 crore, total current assets of Rs. 16.6 crore, total equity of Rs. 87.98 crore, total non-current liabilities of Rs. 76.53 crore and total current liabilities of Rs. 19.33 crore.
Reported under total non-current assets: property, plant and equipment of Rs. 167.23 crore, capital work-in-progress of Rs. 0 crore, intangible assets of Rs. 0.01 crore, right-of-use assets of Rs. 0 crore, deferred tax assets of Rs. 0 crore, investment in quoted shares of Rs. 0 crore, investment in subsidiaries of Rs. 0 crore, other financial assets of Rs. 0 crore and other non-current assets of Rs. 0 crore. Reported under total current assets: inventories of Rs. 5.06 crore, trade receivables of Rs. 9.59 crore, cash and cash equivalents of Rs. 0.29 crore, bank balance (other than cash and cash equivalents) of Rs. 0 crore, advances of Rs. 1.67 crore, income tax assets (net) of Rs. 0 crore, investments in fixed deposit of Rs. 0 crore, prepayments of Rs. 0 crore, other financial assets of Rs. 0 crore and other current assets of Rs. 0 crore. Reported under total equity: share capital of Rs. 68 crore, share premium reserve of Rs. 0 crore, reserve and surplus of Rs. 18.35 crore, retained earnings of Rs. 0 crore, other equity of Rs. 1.63 crore and non-controlling interest of Rs. 0 crore. Reported under total non-current liabilities: long term borrowings of Rs. 64.88 crore, lease liabilities of Rs. 0 crore, deferred tax liabilities (net) of Rs. 7.75 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 3.9 crore and provisions of Rs. 0 crore. Reported under total current liabilities: short term borrowings of Rs. 11.16 crore, trade payables of Rs. 2.14 crore, lease liabilities of Rs. 0 crore, retirement benefit obligation of Rs. 0 crore, other financial liabilities of Rs. 0 crore, other current liabilities of Rs. 6.03 crore, provisions of Rs. 0 crore and income tax liabilities (net) of Rs. 0 crore.
SOPL cash flow for 2081/82
In the financial year 2081/82, Sopan Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 1.51 crore, net cash from operating activities of Rs. 15.33 crore, net cash from investing activities of Rs. 4.19 crore, net cash from financing activities of Rs. 10.66 crore, net change in cash of Rs. 0.48 crore and closing cash & cash equivalents of Rs. 1.03 crore.
Reported under net cash from operating activities: profit before tax of Rs. 24.13 crore, adjustment for depreciation and amortisation of Rs. 1.85 crore, adjustment for finance costs of Rs. 5.69 crore, changes in working capital of Rs. 45.71 crore, income tax paid of Rs. 0 crore and other operating adjustments of Rs. 1.29 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 2.3 crore, proceeds from sale of property, plant and equipment of Rs. 21.49 crore, purchase of investments of Rs. 15 crore, interest received of Rs. 0 crore, dividend received of Rs. 0 crore and other investing activities of Rs. 0 crore. Reported under net cash from financing activities: proceeds from borrowings of Rs. 0 crore, repayment of borrowings of Rs. 15.02 crore, payment of lease liabilities of Rs. 0 crore, dividends paid of Rs. 0 crore, interest paid of Rs. 5.06 crore and other financing activities of Rs. 30.74 crore.
SOPL cash flow for 2080/81
In the financial year 2080/81, Sopan Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 0.29 crore, net cash from operating activities of Rs. 10.9 crore, net cash from investing activities of Rs. 2.27 crore, net cash from financing activities of Rs. 14.4 crore, net change in cash of Rs. 1.22 crore and closing cash & cash equivalents of Rs. 1.51 crore.
Reported under net cash from operating activities: profit before tax of Rs. 10.33 crore, adjustment for depreciation and amortisation of Rs. 1.62 crore, adjustment for finance costs of Rs. 8.53 crore, changes in working capital of Rs. 10.71 crore, income tax paid of Rs. 0 crore and other operating adjustments of Rs. 0 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 2.27 crore, proceeds from sale of property, plant and equipment of Rs. 0 crore, purchase of investments of Rs. 0 crore, interest received of Rs. 0 crore, dividend received of Rs. 0 crore and other investing activities of Rs. 0 crore. Reported under net cash from financing activities: proceeds from borrowings of Rs. 0 crore, repayment of borrowings of Rs. 6.45 crore, payment of lease liabilities of Rs. 0 crore, dividends paid of Rs. 0 crore, interest paid of Rs. 8.53 crore and other financing activities of Rs. 29.37 crore.
SOPL cash flow for 2079/80
In the financial year 2079/80, Sopan Pharmaceuticals Limited reported opening cash & cash equivalents of Rs. 0.21 crore, net cash from operating activities of Rs. 3.7 crore, net cash from investing activities of Rs. 1.49 crore, net cash from financing activities of Rs. 2.28 crore, net change in cash of Rs. 0.08 crore and closing cash & cash equivalents of Rs. 0.29 crore.
Reported under net cash from operating activities: profit before tax of Rs. 18.26 crore, adjustment for depreciation and amortisation of Rs. 1.74 crore, adjustment for finance costs of Rs. 9.47 crore, changes in working capital of Rs. 3.35 crore, income tax paid of Rs. 0 crore and other operating adjustments of Rs. 0 crore. Reported under net cash from investing activities: purchase of property, plant and equipment of Rs. 1.01 crore, proceeds from sale of property, plant and equipment of Rs. 2.5 crore, purchase of investments of Rs. 0 crore, interest received of Rs. 0 crore, dividend received of Rs. 0 crore and other investing activities of Rs. 0 crore. Reported under net cash from financing activities: proceeds from borrowings of Rs. 0 crore, repayment of borrowings of Rs. 0.75 crore, payment of lease liabilities of Rs. 0 crore, dividends paid of Rs. 0 crore, interest paid of Rs. 9.47 crore and other financing activities of Rs. 12.5 crore.
SOPL Profit & Loss
Values in Rs. Crore unless stated otherwise.
| Particulars | 2081/82 | 2080/81 | 2079/80 |
|---|
| Revenue from Operations | 50.1 | 15.2 | 14.0 |
|---|
| Gross Profit | 38.0 | 5.2 | 2.7 |
|---|
| Cost of Sales | -12.0 | -9.9 | -11.3 |
|---|
| Operating Profit | 29.8 | -1.8 | -8.8 |
|---|
| Other Income | 2.0 | 3.0 | 0.01 |
|---|
| Selling and Distribution Expenses | -4.1 | -4.4 | -5.3 |
|---|
| Administrative Expenses | -4.3 | -4.1 | -4.4 |
|---|
| Employee Benefit Expenses | 0.00 | 0.00 | 0.00 |
|---|
| Depreciation and Amortisation | -1.8 | -1.6 | -1.7 |
|---|
| Allowance for Expected Credit Loss | 0.00 | 0.00 | 0.00 |
|---|
| Other Operating Expenses | 0.00 | 0.00 | 0.00 |
|---|
| Profit Before Tax | 24.1 | -10.3 | -18.3 |
|---|
| Finance Costs | -5.7 | -8.5 | -9.5 |
|---|
| Gain on Investments through Fair Value | 0.00 | 0.00 | 0.00 |
|---|
| Net Profit for the Year | 21.8 | -8.3 | -28.7 |
|---|
| Current Tax | 0.00 | 0.00 | 0.00 |
|---|
| Deferred Tax | -2.4 | 2.1 | -10.4 |
|---|
| Prior Period Tax Adjustment | 0.00 | 0.00 | 0.00 |
|---|
SOPL Balance Sheet
Values in Rs. Crore unless stated otherwise.
| Particulars | 2081/82 | 2080/81 | 2079/80 |
|---|
| Total Non-Current Assets | 163 | 168 | 167 |
|---|
| Property, Plant and Equipment | 147 | 168 | 167 |
|---|
| Capital Work-in-Progress | 0.00 | 0.00 | 0.00 |
|---|
| Intangible Assets | 0.00 | 0.00 | 0.01 |
|---|
| Right-of-Use Assets | 0.00 | 0.00 | 0.00 |
|---|
| Deferred Tax Assets | 0.00 | 0.00 | 0.00 |
|---|
| Investment in Quoted Shares | 0.00 | 0.00 | 0.00 |
|---|
| Investment in Subsidiaries | 15.0 | 0.00 | 0.00 |
|---|
| Other Financial Assets | 0.00 | 0.00 | 0.00 |
|---|
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 |
|---|
| Total Current Assets | 70.0 | 29.1 | 16.6 |
|---|
| Inventories | 10.3 | 6.6 | 5.1 |
|---|
| Trade Receivables | 56.3 | 19.2 | 9.6 |
|---|
| Cash and Cash Equivalents | 1.0 | 1.5 | 0.29 |
|---|
| Bank Balance (other than Cash and Cash Equivalents) | 0.00 | 0.00 | 0.00 |
|---|
| Advances | 2.3 | 1.8 | 1.7 |
|---|
| Income Tax Assets (Net) | 0.00 | 0.00 | 0.00 |
|---|
| Investments in Fixed Deposit | 0.00 | 0.00 | 0.00 |
|---|
| Prepayments | 0.00 | 0.00 | 0.00 |
|---|
| Other Financial Assets | 0.00 | 0.00 | 0.00 |
|---|
| Other Current Assets | 0.00 | 0.00 | 0.00 |
|---|
| Total Equity | 162 | 109 | 88.0 |
|---|
| Share Capital | 129 | 99.0 | 68.0 |
|---|
| Share Premium Reserve | 0.00 | 0.00 | 0.00 |
|---|
| Reserve and Surplus | 32.9 | 10.1 | 18.4 |
|---|
| Retained Earnings | 0.00 | 0.00 | 0.00 |
|---|
| Other Equity | 0.00 | 0.00 | 1.6 |
|---|
| Non-Controlling Interest | 0.00 | 0.00 | 0.00 |
|---|
| Total Non-Current Liabilities | 52.4 | 63.4 | 76.5 |
|---|
| Long Term Borrowings | 43.8 | 55.0 | 64.9 |
|---|
| Lease Liabilities | 0.00 | 0.00 | 0.00 |
|---|
| Deferred Tax Liabilities (Net) | 8.0 | 5.7 | 7.7 |
|---|
| Retirement Benefit Obligation | 0.00 | 0.00 | 0.00 |
|---|
| Other Financial Liabilities | 0.50 | 2.8 | 3.9 |
|---|
| Provisions | 0.00 | 0.00 | 0.00 |
|---|
| Total Current Liabilities | 18.5 | 24.5 | 19.3 |
|---|
| Short Term Borrowings | 10.7 | 14.6 | 11.2 |
|---|
| Trade Payables | 4.1 | 2.7 | 2.1 |
|---|
| Lease Liabilities | 0.00 | 0.00 | 0.00 |
|---|
| Retirement Benefit Obligation | 0.00 | 0.00 | 0.00 |
|---|
| Other Financial Liabilities | 0.00 | 0.00 | 0.00 |
|---|
| Other Current Liabilities | 3.7 | 7.1 | 6.0 |
|---|
| Provisions | 0.00 | 0.00 | 0.00 |
|---|
| Income Tax Liabilities (Net) | 0.00 | 0.00 | 0.00 |
|---|
SOPL Cash Flow
Values in Rs. Crore unless stated otherwise.
| Particulars | 2081/82 | 2080/81 | 2079/80 |
|---|
| Opening Cash & Cash Equivalents | 1.5 | 0.29 | 0.21 |
|---|
| Net Cash from Operating Activities | -15.3 | -10.9 | -3.7 |
|---|
| Profit Before Tax | 24.1 | -10.3 | -18.3 |
|---|
| Adjustment for Depreciation and Amortisation | 1.8 | 1.6 | 1.7 |
|---|
| Adjustment for Finance Costs | 5.7 | 8.5 | 9.5 |
|---|
| Changes in Working Capital | -45.7 | -10.7 | 3.3 |
|---|
| Income Tax Paid | 0.00 | 0.00 | 0.00 |
|---|
| Other Operating Adjustments | -1.3 | 0.00 | 0.00 |
|---|
| Net Cash from Investing Activities | 4.2 | -2.3 | 1.5 |
|---|
| Purchase of Property, Plant and Equipment | -2.3 | -2.3 | -1.0 |
|---|
| Proceeds from Sale of Property, Plant and Equipment | 21.5 | 0.00 | 2.5 |
|---|
| Purchase of Investments | -15.0 | 0.00 | 0.00 |
|---|
| Interest Received | 0.00 | 0.00 | 0.00 |
|---|
| Dividend Received | 0.00 | 0.00 | 0.00 |
|---|
| Other Investing Activities | 0.00 | 0.00 | 0.00 |
|---|
| Net Cash from Financing Activities | 10.7 | 14.4 | 2.3 |
|---|
| Proceeds from Borrowings | 0.00 | 0.00 | 0.00 |
|---|
| Repayment of Borrowings | -15.0 | -6.4 | -0.75 |
|---|
| Payment of Lease Liabilities | 0.00 | 0.00 | 0.00 |
|---|
| Dividends Paid | 0.00 | 0.00 | 0.00 |
|---|
| Interest Paid | -5.1 | -8.5 | -9.5 |
|---|
| Other Financing Activities | 30.7 | 29.4 | 12.5 |
|---|
| Net Change in Cash | -0.48 | 1.2 | 0.08 |
|---|
| Closing Cash & Cash Equivalents | 1.0 | 1.5 | 0.29 |
|---|
Sopan Pharmaceuticals share price history
Over the last 15 trading sessions SOPL closed between Rs. 725.00 and Rs. 768.00, finishing at Rs. 748.90 on 2026-09-22 against Rs. 729.00 on 2026-08-26.
| Date | Open | High | Low | Close | Volume |
|---|
| 2026-09-22 | 750.00 | 757.90 | 741.00 | 748.90 | 24,223 |
|---|
| 2026-09-18 | 717.00 | 762.00 | 717.00 | 754.00 | 27,626 |
|---|
| 2026-09-17 | 760.00 | 768.00 | 754.00 | 754.00 | 18,981 |
|---|
| 2026-09-16 | 765.00 | 777.00 | 751.00 | 760.00 | 24,460 |
|---|
| 2026-09-15 | 792.00 | 793.00 | 756.00 | 768.00 | 37,061 |
|---|
| 2026-09-14 | 740.00 | 759.90 | 740.00 | 754.90 | 23,277 |
|---|
| 2026-09-11 | 720.00 | 745.00 | 720.00 | 740.00 | 14,843 |
|---|
| 2026-09-10 | 725.10 | 733.00 | 725.10 | 726.70 | 15,554 |
|---|
| 2026-09-09 | 738.00 | 752.00 | 728.00 | 731.00 | 24,640 |
|---|
| 2026-09-07 | 720.00 | 748.90 | 720.00 | 738.00 | 27,444 |
|---|
| 2026-09-03 | 728.00 | 733.90 | 720.20 | 725.00 | 26,050 |
|---|
| 2026-09-02 | 731.00 | 739.00 | 728.00 | 734.00 | 15,417 |
|---|
| 2026-09-01 | 736.00 | 750.00 | 723.00 | 731.20 | 16,544 |
|---|
| 2026-08-31 | 758.00 | 758.00 | 733.00 | 736.00 | 19,391 |
|---|
| 2026-08-26 | 748.00 | 748.00 | 727.10 | 729.00 | 25,470 |
|---|
Sopan Pharmaceuticals share price returns
At Rs. 748.90 on 2026-09-22, SOPL is down 2.49% over 1 week, down 2.66% over 1 month and down 24.23% over 3 months. Each return compares that close with the last close on or before the same date in the earlier period.
| Period | Return | From price (Rs.) | From date |
|---|
| 1 week | -2.49% | 768.00 | 2026-09-15 |
|---|
| 1 month | -2.66% | 769.40 | 2026-08-21 |
|---|
| 3 months | -24.23% | 988.40 | 2026-06-24 |
|---|
SOPL floorsheet for 2026-09-22
SOPL traded 694 times on 2026-09-22, moving 23,187 shares for Rs. 1.74 crore of turnover. Trades went through between Rs. 741.00 and Rs. 757.90.
Largest buyers by volume: broker 49, Online Securities Limited on 5,000 shares across 63 trades, broker 66, Miyo Securities Pvt Ltd on 3,330 shares across 101 trades, broker 42, Sani Securities Company Limited on 1,804 shares across 20 trades, broker 35, Kohinoor Investment and Securities Pvt.Ltd on 1,530 shares across 56 trades, broker 16, Primo Securities Pvt. Limited on 1,320 shares across 45 trades, broker 56, Sri Hari Securities Pvt.Ltd on 1,005 shares across 10 trades, broker 69, Index Securities Limited on 1,000 shares across 30 trades, broker 58, Naasa Securities Co. Ltd. on 774 shares across 30 trades, broker 91, C.B.I.L. Securities Limited on 640 shares across 1 trades and broker 38, Dipshika Dhitopatra Karobar Co. Pvt.Limited on 570 shares across 41 trades.
Largest sellers by volume: broker 96, Himalayan Securities Limited on 3,020 shares across 4 trades, broker 49, Online Securities Limited on 2,862 shares across 51 trades, broker 58, Naasa Securities Co. Ltd. on 2,474 shares across 152 trades, broker 42, Sani Securities Company Limited on 1,320 shares across 43 trades, broker 45, Imperial Securities Co. Limited on 1,050 shares across 21 trades, broker 21, Midas Stock Broking Company Pvt. Limited on 1,030 shares across 18 trades, broker 10, Pragyan Securities Pvt. Limited on 1,000 shares across 6 trades, broker 61, Bhole Ganesh Securities Limited on 850 shares across 7 trades, broker 57, Arya Tara Investment And Securities Pvt. Ltd. on 799 shares across 30 trades and broker 14, Nepal Stock House Pvt. Limited on 600 shares across 11 trades.
SOPL general meetings
Annual and special general meetings Sopan Pharmaceuticals Limited has called. A dividend is declared by the board and approved at the AGM.
- 16th AGM for 2081/2082: on 2025-08-31, at Aagan Party Venue and Restaurant Pvt.Ltd, Mahalaxmi Municipality-1, Imadol, Lalitpur (11:00 AM)
3 years of annual statements for SOPL, with charts and peer comparison, are free on NepView.
New to these statements? How to read a profit and loss statement, How to read a balance sheet, How to read a cash flow statement, How to read quarterly results.
Other Manufacturing And Processing companies on NEPSE
All manufacturing and processing companies on NEPSE
More on NepView